| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.081 | 0.02 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.071 | 0.02 |
| mRNA | AC55649 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.02 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | 0.082 | 0.03 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.03 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.03 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | -0.08 | 0.03 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.083 | 0.03 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | -0.083 | 0.03 |